Recruitment of patients for clinical trials: the importance of thinking about the patient from the start
Recruiting patients to participate in clinical trials can be a complex and costly process for clinical research promoters. However, considering their needs, emotional situation, scientific understanding, and many other factors is key to achieving high participation from the outset of the research.
The gut microbiota and its impact on human health
The gut microbiota is the collection of microorganisms that inhabit our intestines. These microorganisms play a crucial role in our health, influencing digestive processes, the immune system, and mental health. Therefore, it is critical to conduct clinical research on the microbiota to develop effective treatments.
Sermes CRO obtains ISO 9001 and ISO 27001 quality certificates
The nature of our operations – offering clinical research services and solutions – makes obtaining these certificates particularly relevant for our company.
Keys to effective clinical trial monitoring
Clinical trial monitoring is essential for maintaining the quality and integrity of data. In this article, we delve into the keys to effective monitoring and explore how decentralized trials can benefit pharmaceutical and biotechnology companies
Only 6 months left for the transition of all Clinical Trials to CTIS
The deadline for transitioning clinical trials to CTIS ends on January 30, 2025. Studies continuing beyond this date must comply with the Clinical Trials Regulation (CTR), replacing the old CTD. At Sermes CRO, we join the EMA’s effort to communicate this imminent change to clinical trial sponsors in Europe
Celebrating 25 years of innovation in biotechnology: Sermes CRO at the presentation of the Asebio 2023 report
We attended the presentation of the Asebio 2023 Report, an essential event for the Spanish biotechnology sector. This year is particularly special as Asebio celebrates its 25th anniversary, and at Sermes CRO, we are proud to be part of this ecosystem, having been in the industry for 27 years. The advancements and achievements in this sector are impressive, with collaboration being a crucial pillar
26 days to evaluate your clinical trial thanks to AEMPS’ fast-track assessment
The Spanish Agency for Medicines and Health Products (AEMPS) has implemented a new accelerated assessment procedure for certain clinical trials. This initiative aims to make Spain a more attractive environment for innovative drug research. Below, we explain which trials can take advantage of this fast-track process that reduces the evaluation time from 45 to 26 days
The Essential Role of CROs in Clinical Research
From document management to regulatory strategy, CROs are indispensable partners for the advancement of science and medicine. On Clinical Trials Day, join us on this journey to better understand the vital role that CROs play in the development of innovative treatments and medications.
European Artificial Intelligence Regulation: Missed Opportunity or Protective Shield
One sector significantly impacted by the use and development of Artificial Intelligence is healthcare and by extension Clinical Research The new Regulation is crucial for AI development as it affects not only technological advancement but also our fundamental rights
Sermes CRO has become the first Contract Research Organization to embrace Farmaindustria’s Code of Conduct for Personal Data Treatment
The company aligns itself with Farmaindustria’s guidelines, which oversee the handling of personal data in the realms of clinical trials and other clinical and pharmacovigilance research